Brind.

Norges Bank acquired a new stake in Gilead Sciences, while Boston Partners also bought shares, all filed with the SEC.

1 report, 1 independent Updated Aug 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Gilead Sciences Norges Bank SEC

Keep exploring

The entities involved

Gilead Sciences
American company
- MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Sun 01:24
- TAF's royalty obligation expiration boosted gross margin, and Mercier reported strong sales growth performance.Sat 21:47
Norges Bank
central bank of Norway
- Merck KGaA stock saw activity as an EVP sold shares, while Mirae Asset increased its stake, alongside Norges Bank's previous acquisition.Sun 13:04
- Norges Bank acquired a new position in EMCOR Group, Inc. shares on July 24, 2026.Sun 10:22
SEC
Slovak company
- Pagaya technologies stock traded on the electronic exchange and required stock sales disclosures with the SEC on July 2, 2026.09:41
- Edwards Lifesciences filed insider trading documents with the SEC on November 2, 2026.07:27

Related events

Micron Technology, Norges Bank, and Morgan Stanley are involved in stock purchases and increased holdings as of June 26, 2026, requiring SEC filings.Jun 26

Coverage

Newest first; wire copies grouped

Aug 6themarketsdaily.com